Nobel Committee described their work as ‘a landmark achievement in our battle against viral infections’
MONDAY, Oct. 5, 2020 (HealthDay News) — Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.
Hepatitis C causes 400,000 deaths worldwide each year, The Washington Post reported.
The three recipients are: Harvey Alter, a clinical scientist at a U.S. National Institutes of Health blood bank; Charles Rice, of Washington University in St. Louis; and British-born virologist Michael Houghton.
The researchers’ work was described by the Nobel Committee as “a landmark achievement in our battle against viral infections,” The Post reported.
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy 
Significant Association ID"d Between Hepatitis C, Overactive Bladder 
Birth Dose of Hepatitis B Vaccination Safe, Effective 
Significant Laboratory Costs Associated With Point-of-Care Hepatitis C Testing 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
NEWS2 Scores Can ID Patients With Suspected Sepsis Needing Timely Treatment 
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome 
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma 
